Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis.

Luo MS, Huang GJ, Liu HB.

Medicine (Baltimore). 2019 Jun;98(24):e15951. doi: 10.1097/MD.0000000000015951.

2.

Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.

Zhang B, Mo Z, Du W, Wang Y, Liu L, Wei Y.

Oral Oncol. 2015 Nov;51(11):1041-1046. doi: 10.1016/j.oraloncology.2015.08.005. Epub 2015 Aug 18. Review.

PMID:
26296274
3.

Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Kuang WL, Zhou Q, Shen LF.

Clin Transl Oncol. 2012 Oct;14(10):783-90. doi: 10.1007/s12094-012-0864-5. Epub 2012 Jul 24.

PMID:
22855156
4.

IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06).

Moon SH, Cho KH, Lee CG, Keum KC, Kim YS, Wu HG, Kim JH, Ahn YC, Oh D, Lee JH.

Strahlenther Onkol. 2016 Jun;192(6):377-85. doi: 10.1007/s00066-016-0959-y. Epub 2016 Mar 14. Review.

PMID:
26972085
5.

Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.

Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY.

Eur J Cancer. 2015 Nov;51(17):2587-95. doi: 10.1016/j.ejca.2015.08.006. Epub 2015 Aug 26.

PMID:
26318726
6.

A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.

Qiu WZ, Peng XS, Xia HQ, Huang PY, Guo X, Cao KJ.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1563-1572. doi: 10.1007/s00432-017-2401-y. Epub 2017 Mar 25.

7.

The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.

You R, Cao YS, Huang PY, Chen L, Yang Q, Liu YP, Zou X, Zhang YN, Jiang R, Zhang MX, Duan CY, Lin AH, Hong MH, Chen MY.

Theranostics. 2017 Oct 17;7(19):4825-4835. doi: 10.7150/thno.21815. eCollection 2017.

8.

Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.

Tang LL, Chen L, Mao YP, Li WF, Sun Y, Liu LZ, Lin AH, Mai HQ, Shao JY, Li L, Ma J.

Radiother Oncol. 2015 Aug;116(2):167-73. doi: 10.1016/j.radonc.2015.07.038. Epub 2015 Aug 24.

PMID:
26316395
9.
10.

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.

Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J, Wu G.

Radiother Oncol. 2012 Sep;104(3):286-93. doi: 10.1016/j.radonc.2012.08.013. Epub 2012 Sep 17.

PMID:
22995588
11.

Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy.

Kristensen CA, Kjaer-Kristoffersen F, Sapru W, Berthelsen AK, Loft A, Specht L.

Acta Oncol. 2007;46(2):214-20.

PMID:
17453372
13.

Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.

Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, Huang TL, Huang HY.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):356-64. doi: 10.1016/j.ijrobp.2007.12.054. Epub 2008 Mar 20.

PMID:
18355980
14.

Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma.

Zou X, Han F, Ma WJ, Deng MQ, Jiang R, Guo L, Liu Q, Mai HQ, Hong MH, Chen MY.

Head Neck. 2015 Aug;37(8):1108-15. doi: 10.1002/hed.23719. Epub 2014 Jul 11.

PMID:
24764204
15.

Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.

Pan XB, Huang ST, Chen KH, Jiang YM, Ma JL, Qu S, Li L, Chen L, Zhu XD.

Oncotarget. 2017 Jul 11;8(28):46211-46218. doi: 10.18632/oncotarget.17582.

16.

[Comparison of temporomandibular joint injuries after three-dimensional conformal and intensity-modulated radiotherapies for nasopharyngeal carcinoma].

Chen D, Yu Y, Qi B, Liu J, Li M, Liang Y.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(7):991-4. Chinese.

PMID:
22820584
17.

The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106).

Ha B, Cho KH, Moon SH, Lee CG, Keum KC, Kim YS, Wu HG, Kim JH, Ahn YC, Oh D, Noh JM, Lee JH, Kim SH, Kim WT, Oh YT, Kang MK, Kim JH, Kim JY, Cho MJ, Kay CS, Choi JH.

Cancer Res Treat. 2019 Jan;51(1):12-23. doi: 10.4143/crt.2017.273. Epub 2018 Feb 5.

18.

Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.

Luo Y, Qin Y, Lang J.

Clin Transl Oncol. 2017 Apr;19(4):470-476. doi: 10.1007/s12094-016-1551-8. Epub 2016 Oct 7.

PMID:
27718153
19.

Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.

Yang H, Chen X, Lin S, Rong J, Yang M, Wen Q, Shang C, He L, Ren P, Xu S, Zhang J, Liu Q, Pang H, Shi X, Fan J, Sun X, Ma D, Tan B, Zhang T, Zhang L, Hu D, Du X, Zhang Y, Wen S, Zhang X, Wu J.

Radiother Oncol. 2018 Jan;126(1):37-42. doi: 10.1016/j.radonc.2017.07.020. Epub 2017 Aug 29.

PMID:
28864073
20.

Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.

Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY, Lou PJ, Wang CW.

Oncotarget. 2017 Feb 21;8(8):14068-14077. doi: 10.18632/oncotarget.12736.

Supplemental Content

Support Center